UPDATE: Citigroup Reiterates Buy Rating, Raises PT on Zoetis Following Pershing Confirmation


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


In a report published Wednesday, Citigroup analyst Liav Abraham reiterated a Buy rating on

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Zoetis (NYSE: ZTS), and raised the price target from $44.00 to $49.00.In the report, Citigroup noted, “Following its accumulation of a 9.7% stake in AGN earlier this year, activist hedge fund Pershing Square has confirmed the accumulation of a 10% stake in ZTS. We assume that Pershing is interested in advocating for a sale of ZTS, potentially to VRX if its bid for AGN falls through. Apart from VRX, we note that others, including Bayer, could be interested in acquiring the company. We note CFO Paul Herendeen's commentary on last week's earnings call, which focused on maximizing shareholder value, while not ruling out a potential sale of the company. We anticipate that today's news will constitute the focus of attention at ZTS' analyst day next week (November 18th).”Zoetis closed on Tuesday at $43.72.
Posted In: Analyst ColorPrice TargetAnalyst RatingsCitigroupLiav Abraham